Case Investigations

GoPro, Inc.

January 17, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GoPro, Inc. (“GoPro” or the “Company”) (NASDAQ: GPRO).  Investors who purchased GoPro securities between August 4, 2017 and January 5, 2018, inclusive (the “Class Period”) may be affected.

AZZ, Inc.

January 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of AZZ Inc. (“AZZ” or the “Company”) (NYSE: AZZ).  Investors who purchased shares of AZZ securities may be affected.

Capitala Finance Corp.

January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Capitala Finance Corp. (“Capitala ” or the “Company”) (NASDAQ: CPTA).  Investors who purchased Capitala shares may be affected.

The Crypto Company

January 9, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Crypto Company (“Crypto” or the “Company”) (OTC: CRCW).  Crypto is a technology company that operates in the digital currencies and blockchain sector.  The Company offers a portfolio of digital assets, technologies, and consulting services to the blockchain and cryptocurrency markets.  Investors who purchased Crypto common shares may be affected.

Liberty Tax, Inc.

December 12, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Liberty Tax, Inc. (“Liberty Tax” or the “Company”) (NASDAQ: TAX).  Investors who purchased shares of Liberty Tax securities may be affected.

Omega Healthcare Investors, Inc.

November 29, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Omega Healthcare Investors, Inc. (“Omega Healthcare” or the “Company”) (NYSE: OHI), a real estate investment trust (REIT) that invests in income producing healthcare facilities.  Investors who purchased Omega Healthcare common stock may be affected.

Triangle Capital Corporation

November 16, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Triangle Capital Corporation ("Triangle Capital" or the "Company") (NYSE: TCAP).  Investors who purchased Triangle Capital common stock may be affected.

Acorda Therapeutics, Inc.

November 15, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).

Genocea Biosciences, Inc.

November 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Genocea Biosciences, Inc. (“Genocea” or the “Company”) (NASDAQ: GNCA).  Genocea is a biopharmaceutical company developing vaccines and immunotherapies.

Trivago N.V.

November 7, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trivago N.V. (“Trivago” or the “Company”) (NASDAQ: TRVG).

The Advisory Board Company

September 6, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating The Advisory Board Company ("Advisory Board” or the "Company") (NASDAQ: ABCO), a company that provides performance-improvement software and services to the healthcare and education industries.  Investors who purchased shares of Advisory Board common stock may be affected.

SteadyMed Ltd.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. (“SteadyMed” or the “Company”) (NASDAQ: STDY).

DryShips Inc.

September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DryShips Inc. (“DryShips” or the “Company”) (NASDAQ: DRYS).